Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

79
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
79
Brainstem01:19

Brainstem

3.7K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
3.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

887
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
887
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

469
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
469
Neural Regulation01:37

Neural Regulation

40.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Cortical GABAergic dysfunction underlying abnormal hand movements in ARX mutation.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2019
Same author

Gelastic Cataplexy in Niemann Pick Type C.

Movement disorders clinical practice·2019
Same author

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Molecular neurobiology·2019
Same author

Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.

Pediatric neurology·2019
Same author

Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2019
Same author

Deep brain stimulation in status dystonicus caused by anti-NMDA receptor encephalitis.

Parkinsonism & related disorders·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Oct 22, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K

Enfermedad de Parkinson enfermedad de Parkinson.

Lorraine V Kalia1, Anthony E Lang1

  • 1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Lancet (London, England)
|April 24, 2015
PubMed
Resumen

La enfermedad de Parkinson (EP) presenta síntomas motores y no motores complejos, patología y causas desconocidas. Los tratamientos actuales manejan los síntomas pero no retrasan la neurodegeneración, lo que pone de relieve importantes desafíos clínicos.

Más Videos Relacionados

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.4K

Videos de Experimentos Relacionados

Last Updated: Oct 22, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.4K

Área de la Ciencia:

  • Neurología Neurología.
  • La neurociencia es la neurociencia.
  • Patología Patología Patología.

Sus antecedentes:

  • La enfermedad de Parkinson (EP) se define tradicionalmente por los síntomas motores, los cuerpos de Lewy y la pérdida de neuronas de la sustancia negra.
  • La comprensión reciente revela la heterogeneidad de la EP, que abarca características no motoras significativas y una patología generalizada más allá de los cuerpos de Lewy.
  • La etiología de la EP es multifactorial, e implica una compleja interacción entre factores genéticos y ambientales que afectan los procesos celulares.

Objetivo del estudio:

  • Para revisar la evolución de las complejidades de la enfermedad de Parkinson.
  • Para discutir los desafíos clínicos asociados con el diagnóstico y el manejo de la enfermedad de Parkinson.
  • Para resaltar las limitaciones de los enfoques terapéuticos actuales para la enfermedad de Parkinson.

Principales métodos:

  • Revisión de la literatura sobre la enfermedad de Parkinson.
  • Análisis de la comprensión actual de la sintomatología y patología de la EP.
  • Examen de los desafíos diagnósticos y terapéuticos en la enfermedad de Parkinson.

Principales resultados:

  • La enfermedad de Parkinson exhibe síntomas motores y no motores heterogéneos.
  • La patología se extiende más allá de la sustancia negra, involucrando múltiples neurotransmisores y agregados de proteínas.
  • El diagnóstico precoz y el manejo eficaz de los síntomas siguen siendo un desafío, ya que no hay tratamientos que modifiquen la enfermedad disponibles.

Conclusiones:

  • La enfermedad de Parkinson es un trastorno neurológico complejo con patología y sintomatología multifacética.
  • Existen desafíos clínicos significativos en el diagnóstico temprano, el manejo de los síntomas y la falta de terapias neuroprotectoras.
  • Se necesita más investigación para desentrañar las complejidades de la EP y desarrollar tratamientos efectivos.